Rabies vaccine

A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Safety and Immunogenicity of ID vs IM Rabies Vaccine

Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Study to Evaluate GR1801's Efficacy and Safety

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Responses to Rabies Vaccine in Adults With or Without Antibiotics

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

Immunity Persistence After Abridged Intradermal Rabies PEP

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults

A Bridging Study of the SYN023 on Healthy Adult Subjects

Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.